Hologic, Inc. (LON:0J5Q)

Market Cap	11.45B
Revenue (ttm)	3.21B
Net Income (ttm)	590.92M
Shares Out	n/a
EPS (ttm)	2.51
PE Ratio	19.37
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	2,715
Average Volume	753
Open	64.14
Previous Close	64.51
Day's Range	63.97 - 64.51
52-Week Range	64.50 - 86.55
Beta	0.98
RSI	31.36
Earnings Date	Jan 30, 2025

About Hologic

Hologic, Inc. engages in the development, manufacture, and supply of diagnostics products, medical imaging systems, and surgical products for women's health through early detection and treatment worldwide. The company operates through four segments: Diagnostics, Breast Health, GYN Surgical, and Skeletal Health. It provides Aptima molecular diagnostic assays to detect the infectious microorganisms; Aptima viral load assays for Hepatitis B virus, Hepatitis C virus, human immunodeficiency virus, and human cytomegalo virus; Aptima bacterial vaginos...

• Industry: Medical - Equipment & Services
• Sector: Healthcare
• Founded: 1985
• Employees: 7,063
• Stock Exchange: London Stock Exchange
• Ticker Symbol: 0J5Q

Financial Performance

In 2024, Hologic's revenue was $4.03 billion, a decrease of -0.00% compared to the previous year's $4.03 billion. Earnings were $789.50 million, an increase of 73.14%.

Financial numbers in USD